Enhanced Self-Replicating Cell Selective Gene Delivery Compositions and Methods

Improved gene delivery compositions and methods that enable targeted, efficient, and safe gene expression in specific cell types, overcoming limitations of existing self-replicating polyribonucleotide-based approaches.

Despite the progress in gene therapy, existing self-replicating polyribonucleotide-based approaches suffer from limitations, including off-target effects, inefficient gene expression, and lack of cell-type specificity. The new inventive concept addresses these limitations by incorporating cell-type specific promoters, receptors, and microRNA target sequences, ensuring targeted gene delivery and reducing off-target effects.

The enhanced self-replicating polyribonucleotide compositions comprise cell-type specific promoters, receptors, and microRNA target sequences, enabling targeted uptake by specific cell types. The polyribonucleotides can be administered via various delivery vehicles, including viral vectors, lipids, and nanoparticles. The inventive concept also encompasses methods for delivering genes to specific cell types, enhancing gene expression, and treating diseases using these compositions.

The new claims introduce novel features, including cell-type specific promoters, receptors, and microRNA target sequences, which significantly improve the specificity, efficiency, and safety of gene delivery. These features are not obvious in light of the original patent and represent a significant advancement in the field.

Alternative embodiments of the inventive concept include using different types of promoters, receptors, and microRNA target sequences, as well as combining these elements in various ways to achieve targeted gene delivery. Variations of the inventive concept could also include using different delivery vehicles, such as electroporation or sonoporation, to enhance gene expression.

The enhanced self-replicating polyribonucleotide compositions and methods have significant commercial potential in the gene therapy market, particularly for treating genetic disorders, cancer, and infectious diseases. The targeted and efficient gene delivery enabled by this inventive concept could lead to improved treatment outcomes, reduced side effects, and increased patient safety.